Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

EMN vs FMC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EMN Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

EMN Overall Winner 6-Pillar Tally: EMN 3 – 3 FMC Matrix Metrics: EMN 7 – 3 FMC

As of Nov 17, 2026, Eastman Chemical Company (EMN) is the stronger overall head-to-head candidate over FMC Corporation (FMC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). EMN carries a Unified Composite Score of 46.4/100 (HOLD) at $62.38 (9.7x Forward P/E, 10.7% operating margin), whereas FMC carries 46.7/100 (HOLD) at $4.96 (5.5x Forward P/E, -15.7% operating margin).

  • Technical & Structure Timing Caution: EMN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0); meanwhile FMC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EMN vs FMC
EMN NYSE Head-to-Head Winner
Eastman Chemical Company
Plastic Materials, Synth Resins & Nonvulcan Elastomers
$62.38
-1.76% 1D
Market Cap $7.4B
TTM Revenue $9.05B
Forward P/E 9.7x
Beta / 30D Vol 0.80β · 28% Vol
Unified Composite Score
46.4 / 100 HOLD
Tech 41.0 Fund 53.0 Flow 60.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 39
RSI-14: 39.0 · SMA20: $65.52 · SMA50: $65.24
FMC NYSE
FMC Corporation
Chemicals & Allied Products
$4.96
-5.07% 1D
Market Cap $810.5M
TTM Revenue $2.81B
Forward P/E 5.5x
Beta / 30D Vol 0.21β · 132% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 67.0 Mom 74.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -23.5%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $5.39 · SMA50: $7.64

6-Pillar Scorecard Institutional Category Breakdown (EMN 3 – 3 FMC)

Columns: Metric · EMN · FMC
1. Valuation Multiples FMC
Forward P/E 9.7x 5.5x
Trailing P/E 11.6x 4.2x
PEG Ratio 0.64x 0.46x
EV / Revenue 1.3x 1.5x
2. Growth & Scale EMN
Revenue Growth (YoY) +8.3% -80.5%
Earnings Growth (YoY) +265.0% -77.6%
TTM Revenue (USD) $9.05B $2.81B
Market Cap $7.4B $810.5M
3. Profitability & Quality EMN
Gross Margin 20.3% 17.6%
Operating Margin 10.7% -15.7%
Net Profit Margin 6.9% -151.2%
Return on Equity (ROE) 10.3% -218.9%
4. Balance Sheet & Cash Flow EMN
Cash Generation (TTM) $1.50B EBITDA $296M
Cash Flow Margin 16.6% EBITDA Mgn 10.5%
Net Cash / Leverage $4.45B Net Debt (0.83x D/E) $3.44B Net Debt
Dividend Yield 5.12% 6.32%
5. Options & Positioning FMC
Options Structure Phase CONSOLIDATION SURGE
Current IV / %ile 38.5% (50th %ile) 104.3% (100th %ile)
Put/Call OI Skew 0.22x (Call-Skewed) 0.82x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat FMC
OpEx & R&D Intensity 9.6% of Rev ($869M) 33.3% of Rev ($937M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Agricultural Inputs Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EMN (7) vs FMC (3)
Institutional Metric EMN FMC Criterion Row Edge
Market Capitalization
Scale
$7.4B $810.5M Larger Scale EMN
Trailing P/E Ratio
Valuation
11.6x 4.2x Lower Multiple FMC
Forward P/E Ratio
Valuation
9.7x 5.5x Lower Multiple FMC
Revenue Growth (YoY)
Growth
+8.3% -80.5% Higher Growth EMN
Operating Margin (TTM)
Profitability
10.7% -15.7% Higher Margin EMN
Net Profit Margin
Profitability
6.9% -151.2% Higher Margin EMN
Return on Equity (ROE)
Capital Efficiency
10.3% -218.9% Higher ROE EMN
52-Week Range Position
Momentum
23% ($56–$83) 4% ($4–$18) Stronger Trend EMN
Beta / 30D Volatility
Risk Regime
0.80β · 28% Vol 0.21β · 132% Vol Lower Realized Risk EMN
Unified Institutional Score
Composite Signal
46.4 / 100 (HOLD) 46.7 / 100 (HOLD) Higher Composite FMC
Trailing 12M Revenue (USD)
Operating Scale
$9.05B $2.81B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
20.3% 17.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.64x PEG · 1.3x EV/Rev 0.46x PEG · 1.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.50B EBITDA ($4.45B Net Debt (0.83x D/E)) $296M ($3.44B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EMN +7.2 pp
EMN: -0.17% · FMC: -7.37%
3M Horizon EMN +37.06 pp
EMN: -17.01% · FMC: -54.07%
6M Horizon EMN +52.62 pp
EMN: -8.47% · FMC: -61.09%
1Y Horizon EMN +67.81 pp
EMN: +3.53% · FMC: -64.28%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EMN Revenue FMC Revenue EMN Op. Margin FMC Op. Margin Margin Leader
FY2018 $10.2B $4.29B 10.6% 17.3% FMC
FY2019 $9.27B $4.61B 8.2% 17.8% FMC
FY2020 $8.47B $4.64B 5.6% 19.3% FMC
FY2021 $10.5B $5.05B 8.2% 20.5% FMC
FY2022 $10.6B $5.80B 7.5% 19.7% FMC
FY2023 $9.21B $4.49B 9.7% 12.4% FMC
FY2024 $9.38B $4.25B 9.6% 11.9% FMC
FY2025 $8.75B $3.47B 5.4% -47.0% EMN

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EMN CONSOLIDATION
138d in phase · OBV NEUTRAL
Current IV 38.5%
IV Percentile 50th %ile
Put/Call OI Skew 0.22x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact EMN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FMC SURGE
11d in phase · OBV NEUTRAL
Current IV 104.3%
IV Percentile 100th %ile
Put/Call OI Skew 0.82x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FMC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $63.49 · IV 36.2%

EMN Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($6,349)

Compare $6,349 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 36.2% ATM IV.

PUT-WALL MONTHLY INCOME Liq B

Dec 18 $60 / $55 Bull Put Spread

Sell 1x $60P · Buy 1x $55P · 31d

Net Entry $93 Credit
Max Credit / Yield +$93 (+22.9% RoM)
Max Risk / Buffer -7.0% Cushion ($407 Mgn)
5d Edge & Liquidity 73% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $65 / $60 Bear Put Spread

Buy 1x $65P · Sell 1x $60P · 31d

Net Entry $200 Debit
T+5d @ -5% Drop +$100 (+50%)
Max Risk / Buffer $200 Capped
5d Edge & Liquidity 1.0x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EMN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $7.4B market capitalization and 10.7% operating margin.
OpEx & R&D Reinvestment 9.6% of Rev ($869M)
90D Engineering Disclosures 0 Published
FMC Moat Profile Cyclical / Execution-Driven Positioning
Agricultural Inputs Operator
Competes within the Agricultural Inputs value chain with $810.5M market capitalization and -15.7% operating margin.
OpEx & R&D Reinvestment 33.3% of Rev ($937M)
90D Engineering Disclosures 0 Published

Investor FAQ EMN vs FMC Key Questions & Quantitative Answers

As of Nov 17, 2026, Eastman Chemical Company (EMN) is the stronger overall head-to-head candidate over FMC Corporation (FMC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). EMN carries a Unified Composite Score of 46.4/100 (HOLD) at $62.38 (9.7x Forward P/E, 10.7% operating margin), whereas FMC carries 46.7/100 (HOLD) at $4.96 (5.5x Forward P/E, -15.7% operating margin). Technical & Structure Timing Caution: EMN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0); meanwhile FMC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

EMN leads the Growth & Scale pillar: EMN posts +8.3% YoY revenue growth and +265.0% YoY earnings growth on $9.05B TTM revenue (20.3% gross margin, 10.7% operating margin), compared with FMC at -80.5% YoY revenue growth and -77.6% YoY earnings growth on $2.81B TTM revenue (17.6% gross margin, -15.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EMN cumulative revenue shifted -13.8% while FMC shifted -19.1%. In operating R&D and SG&A reinvestment, EMN deploys 9.6% of Rev ($869M) (0 90-day corporate R&D disclosures) versus 33.3% of Rev ($937M) (0 disclosures) for FMC.

FMC screens cheaper on headline valuation multiples. EMN trades at 9.7x Forward P/E, 11.6x Trailing P/E, 0.64x PEG, and 1.3x EV/Revenue (16.6% EBITDA margin), whereas FMC trades at 5.5x Forward P/E, 4.2x Trailing P/E, 0.46x PEG, and 1.5x EV/Revenue (10.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EMN (10.3% ROE) versus FMC (-218.9% ROE) capital efficiency.

In options market volatility and institutional positioning, EMN carries 38.5% implied volatility (50th %ile, Balanced (25th–60th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.80β · 28% Vol realized risk). By comparison, FMC carries 104.3% implied volatility (100th %ile, Extreme (>80th %ile)), a 0.82x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.21β · 132% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.